基于Bifidobacterium的益生菌的汇编:人类疾病的特征和治疗影响
Fabiana Bocchio1,2, Leonardo Mancabelli1,3,2, Christian Milani3,4
1Department of Medicine and Surgery, University of Parma, Parma 43124, Italy.
Microbiome research reports
|April 10, 2025
概括
益生菌Bifidobacterium物种为肠道,呼吸道,骨,肌肉和神经系统提供显著的健康益处. 需要进一步的研究来证实它们在各种人类生理系统中的临床疗效.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 人类微生物群对于健康和疾病预防至关重要.
- Bifidobacterium物种被公认为具有治疗潜力的强效益生菌.
研究的目的:
- 为了审查益生菌的概念.
- 探索Bifidobacterium在多个身体系统对人类健康的影响.
- 将遗传洞察纳入Bifidobacterium的有益作用.
主要方法:
- 关于Bifidobacterium益生菌的科学研究的文献综述.
- 对Bifidobacterium对胃肠道,呼吸道,骨,肌肉和神经系统的影响的研究分析.
- 与益生菌机制相关的遗传数据的整合.
主要成果:
- 双杆菌益生菌有效地管理胃肠道问题,如IBS,IBD和H. pylori感染.
- 这些益生菌可以减少呼吸道感染和喘严重程度.
- 双菌种对骨,肌肉和神经系统的健康,包括关节炎,焦虑和抑郁症,显示出有前途.
结论:
- 基于Bifidobacterium的益生菌显示出广泛的健康益处.
- 需要进一步的临床研究来验证在各种生理系统中的疗效.
相关概念视频
Bacterial Flora of the Large Intestine
400
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
400
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
328
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
328
Inflammatory Bowel Disease IV: Pharmacological Management
122
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
122
What is Monogastric Digestion?
70.9K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
70.9K
Drugs for Treatment of Constipation-Predominant IBS
146
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
146
Drugs for Treatment of Ulcerative Colitis in IBD
130
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
130


